WHO ICTRP trial
Use of a supplement called Memovigor-2 in tinnitus (a condition where a person…
ISRCTN16025480 · International Standard Randomised Controlled Trial Number (ISRCTN) · Not Recruiting
Key facts
| Trial ID | ISRCTN16025480 |
|---|---|
| Public title | Use of a supplement called Memovigor-2 in tinnitus (a condition where a person hears a ringing or buzzing sound in their ears) |
| Scientific title | Memovigor-2 improves tinnitus in patients with recent onset disease: A randomized placebo-controlled study |
| Primary sponsor | Tzaneio General Hospital of Piraeus |
| Registry | International Standard Randomised Controlled Trial Number (ISRCTN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not Applicable |
| Countries | Greece |
| Conditions | Tinnitus Ear, Nose and Throat |
| Interventions | Patients participating in the research group (50%) are given 1 tablet 900 mg of Memovigor 2 (Bionat, Athens, Greece) daily for 3 months. Similar use of placebo is used in the remaining 50%, the control group. A sealed envelope with either… |
| Registration date | May 4, 2023 |
| Target size | 160 |
| Secondary IDs | Nil known;Nil known;14549-18/11/2019 |
| Registry page | isrctn.com |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: